Dr. David Cornutt, M.D

NPI: 1508928813
Total Payments
$52,463
2024 Payments
$32.11
Companies
12
Transactions
89
Medicare Patients
1,245
Medicare Billing
$99,532

Payment Breakdown by Category

Other$26,147 (49.8%)
Travel$15,640 (29.8%)
Consulting$8,496 (16.2%)
Food & Beverage$1,181 (2.3%)
Education$997.92 (1.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $24,147 11 46.0%
Travel and Lodging $15,640 20 29.8%
Consulting Fee $8,496 4 16.2%
Honoraria $2,000 1 3.8%
Food and Beverage $1,181 32 2.3%
Education $997.92 21 1.9%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $20,755 15 $0 (2019)
Boehringer Ingelheim International GmbH $14,900 14 $0 (2019)
Alexion Pharmaceuticals, Inc. $11,923 17 $0 (2023)
PORTOLA PHARMACEUTICALS, LLC $2,726 6 $0 (2020)
CSL Behring $1,012 22 $0 (2018)
AstraZeneca Pharmaceuticals LP $932.11 3 $0 (2024)
PFIZER INC. $88.90 5 $0 (2023)
Bard Access Systems, Inc. $55.75 3 $0 (2017)
Vapotherm Inc $25.43 1 $0 (2021)
Janssen Pharmaceuticals, Inc $17.56 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $32.11 1 AstraZeneca Pharmaceuticals LP ($32.11)
2023 $42.46 2 PFIZER INC. ($21.68)
2022 $3,086 4 Alexion Pharmaceuticals, Inc. ($2,186)
2021 $9,770 17 Alexion Pharmaceuticals, Inc. ($9,716)
2020 $2,692 5 PORTOLA PHARMACEUTICALS, LLC ($2,675)
2019 $26,752 15 Boehringer Ingelheim International GmbH ($14,900)
2018 $6,964 35 Boehringer Ingelheim Pharmaceuticals, Inc. ($5,884)
2017 $3,124 10 Boehringer Ingelheim Pharmaceuticals, Inc. ($3,019)

All Payment Transactions

89 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
06/12/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $32.11 General
Category: Rare Disease
11/15/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $21.68 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
01/09/2023 Alexion Pharmaceuticals, Inc. ANDEXXA (Biological) Food and Beverage In-kind items and services $20.78 General
Category: Rare Disease
07/13/2022 Alexion Pharmaceuticals, Inc. ANDEXXA (Biological) Food and Beverage In-kind items and services $51.11 General
Category: Rare Disease
05/10/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $450.00 General
Category: Rare Disease
05/05/2022 Alexion Pharmaceuticals, Inc. ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,135.00 General
Category: Rare Disease
02/20/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $450.00 General
Category: Rare Disease
12/09/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Travel and Lodging Cash or cash equivalent $465.36 General
Category: Hematology
12/07/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Travel and Lodging Cash or cash equivalent $446.88 General
Category: Hematology
11/18/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,830.00 General
Category: Hematology
11/16/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,830.00 General
Category: Hematology
11/09/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $610.00 General
Category: Hematology
11/09/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Travel and Lodging In-kind items and services $164.25 General
Category: Hematology
11/09/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Food and Beverage In-kind items and services $124.77 General
Category: Hematology
11/04/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Travel and Lodging In-kind items and services $430.08 General
Category: Hematology
11/04/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Food and Beverage In-kind items and services $97.14 General
Category: Hematology
10/20/2021 AbbVie Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $12.50 General
Category: ANTI-INFECTIVE
09/08/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Consulting Fee Cash or cash equivalent $991.25 General
Category: Hematology
09/07/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,135.00 General
Category: Hematology
08/12/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Travel and Lodging In-kind items and services $256.32 General
Category: Hematology
07/19/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Food and Beverage In-kind items and services $30.07 General
Category: Hematology
06/17/2021 Vapotherm Inc VAPOTHERM (Device) Food and Beverage In-kind items and services $25.43 General
Category: RESPIRATORY
05/04/2021 PFIZER INC. ELIQUIS (Drug), VYNDAQEL Food and Beverage In-kind items and services $15.52 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
04/22/2021 Alexion Pharmaceuticals, Inc. Andexxa (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $305.00 General
Category: Hematology
02/25/2020 PORTOLA PHARMACEUTICALS, LLC ANDEXXA (Biological) Honoraria Cash or cash equivalent $2,000.00 General
Category: HEMATOLOGY/NEUROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 383 400 $331,607 $35,198
2022 4 347 351 $231,608 $26,479
2021 4 289 293 $175,324 $22,796
2020 4 226 235 $119,934 $15,059
Total Patients
1,245
Total Services
1,279
Medicare Billing
$99,532
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 134 141 $161,205 $17,449 10.8%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 167 175 $132,108 $14,436 10.9%
99283 Emergency department visit with low level of medical decision making Facility 2023 70 72 $37,971 $3,241 8.5%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 12 12 $322.80 $72.60 22.5%
99284 Emergency department visit for problem of high severity Facility 2022 121 123 $86,436 $10,403 12.0%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 82 82 $87,143 $10,340 11.9%
99283 Emergency department visit for problem of moderate severity Facility 2022 81 83 $40,859 $3,914 9.6%
99282 Emergency department visit for problem of mild to moderate severity Facility 2022 63 63 $17,171 $1,823 10.6%
99284 Emergency department visit, problem of high severity Facility 2021 113 114 $75,392 $10,280 13.6%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 46 46 $47,338 $6,458 13.6%
99283 Emergency department visit, moderately severe problem Facility 2021 91 94 $42,713 $4,977 11.7%
99282 Emergency department visit, low to moderately severe problem Facility 2021 39 39 $9,882 $1,082 10.9%
99284 Emergency department visit, problem of high severity Facility 2020 106 108 $65,641 $8,869 13.5%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 21 21 $19,203 $2,495 13.0%
99283 Emergency department visit, moderately severe problem Facility 2020 55 57 $23,626 $2,316 9.8%
99282 Emergency department visit, low to moderately severe problem Facility 2020 44 49 $11,464 $1,379 12.0%

About Dr. David Cornutt, M.D

Dr. David Cornutt, M.D is a Emergency Medicine healthcare provider based in Scottsbluff, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508928813.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Cornutt, M.D has received a total of $52,463 in payments from pharmaceutical and medical device companies, with $32.11 received in 2024. These payments were reported across 89 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,147).

As a Medicare-enrolled provider, Cornutt has provided services to 1,245 Medicare beneficiaries, totaling 1,279 services with total Medicare billing of $99,532. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Location Scottsbluff, NE
  • Active Since 12/14/2006
  • Last Updated 02/05/2015
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1508928813

Products in Payments

  • PRAXBIND (Drug) $18,860
  • PRADAXA (Drug) $16,795
  • Andexxa (Drug) $9,716
  • ANDEXXA (Biological) $5,814
  • Kcentra (Biological) $1,012
  • BAS-PowerPICC (Device) $55.75
  • CHANTIX (Drug) $51.70
  • ELIQUIS (Drug) $51.60
  • BEVYXXA (Drug) $35.15
  • VAPOTHERM (Device) $25.43
  • XARELTO (Drug) $17.56
  • ANDEXXA (Drug) $16.15
  • DALVANCE (Drug) $12.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Scottsbluff